Related Experiment Video

Updated: Aug 2, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Bacterial Meningitis

Roos1

  • 1Department of Neurology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Current Treatment Options in Neurology
|November 30, 2000
PubMed

Insights

Empiric treatment for bacterial meningitis requires antibiotics like cefotaxime and vancomycin to combat resistant pneumococci. Dexamethasone, an anti-inflammatory, improves patient outcomes when given with initial antibiotics.

Area of Science:

  • Infectious Diseases
  • Neuroscience
  • Pharmacology

Background:

  • Community-acquired bacterial meningitis necessitates prompt and effective empiric therapy.
  • Penicillin-resistant Streptococcus pneumoniae poses a significant challenge in meningitis treatment.
  • Inflammatory cytokines play a critical role in the pathophysiology of bacterial meningitis.

Purpose of the Study:

  • To outline optimal initial empiric antibiotic therapy for community-acquired bacterial meningitis.
  • To evaluate the role of dexamethasone in improving outcomes for bacterial meningitis patients.
  • To highlight the importance of targeting inflammatory responses in meningitis management.

Main Methods:

  • Review of current guidelines and clinical trial data for empiric meningitis treatment.
  • Analysis of the impact of dexamethasone on inflammatory cytokine synthesis (interleukin-1, tumor necrosis factor).
  • Assessment of antimicrobial susceptibility testing for cerebrospinal fluid isolates.

Main Results:

  • Initial therapy should combine a third-generation cephalosporin (cefotaxime or ceftriaxone) with vancomycin to cover resistant pneumococci.
  • Ampicillin should be added for patients at risk of Listeria monocytogenes infection.
  • Clinical trials and meta-analyses indicate dexamethasone improves outcomes when administered with the first antibiotic dose.

Conclusions:

  • Optimal empiric therapy for bacterial meningitis involves broad-spectrum antibiotics and consideration of specific pathogens.
  • Dexamethasone administration concurrent with or prior to antibiotics is crucial for improving patient prognosis.
  • Future therapeutic strategies should focus on modulating host inflammatory responses, potentially through cytokine-targeted therapies.

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells10:12

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells

Published on: July 14, 2020

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...